Pediatric rosacea

Dermatologic Therapy

Volumn 19, Issue 4, 2006, Pages 196-201

  Kroshinsky, Daniela ^a   Glick, Sharon A ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Pediatrics; Rosacea; Therapy

Indexed keywords

AZELAIC ACID; AZITHROMYCIN; BENZOYL PEROXIDE; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; METRONIDAZOLE; MINOCYCLINE; RETINOIC ACID; SULFACETAMIDE; TETRACYCLINE;

ACNE VULGARIS; BURNING SENSATION; CLINICAL FEATURE; CONTACT DERMATITIS; CREAM; DEMODICIDOSIS; DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG FORMULATION; ERYTHEMA; GASTROINTESTINAL DISEASE; GEL; HUMAN; LIVER TOXICITY; LOTION; LYMPHOPROLIFERATIVE DISEASE; PHOTOSENSITIVITY; PRURITUS; RASH; REVIEW; ROSACEA; SARCOIDOSIS; SIDE EFFECT; SKIN DISEASE; SKIN IRRITATION; SKIN PIGMENTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; XEROSIS;

ANTI-INFECTIVE AGENTS; CHILD; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DIET; HUMANS; ROSACEA; SKIN CARE; SUNSCREENING AGENTS;

EID: 33748645121     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2006.00075.x     Document Type: Review

References (40)

1. Webster GF. Rosacea and related disorders. In: Bolognia JL, Jorizzo JL, Rapini RP, et al. Dermatology, 1st ed. New York: Mosby, 2003: 545-551.
2. Lacz N, Schwartz R. Rosacea in the pediatric population. Cutis 2004: 74: 99-103.
3. Howard R, Tsuchiya A. Adult skin disease in the pediatric patient. Dermatol Clin 1998: 16: 593-608.
4. Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004: 51: 327-341.
5. Drolet B, Paller AS. Childhood rosacea. Pediatr Dermatol 1992: 9: 22-26.
6. Nazir SA, Murphy S, Siatkowski RM, et al. Ocular rosacea in childhood. Am J Ophthalmol 2004: 137: 138-144.
7. Erzurum S, Feder R, Greenwald M. Acne rosacea with keratitis in childhood. Arch Ophthalmol 1993: 111: 228-230.
8. Stone D, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol 2004: 15: 499-502.
9. Firooz A, Firoozabadi MR, Dowlati Y. Rosacea fulminans (pyoderma faciale): successful treatment of a 3-year-old girl with oral isotretinoin. Int J Dermatol 2001: 40: 191-209.
10. Dubus JC, Marguet C, Deschildre A, et al. Local side effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy 2001: 56: 944-948.
11. Franco H, Weston W. Steroid rosacea in children. Pediatrics 1979: 64: 36-38.
12. Weston W, Morelli J. Steroid rosacea in prepubertal children. Arch Pediatr Adolesc Med 2000: 154: 62-64.
13. Tarm K, Creel N, Krivda S, Turiansky G. Granulomatous periorificial dermatitis. Cutis 2004: 73: 399-402.
14. Urbatsch AJ, Frieden I, Williams M, et al. Extrafacial and generalized granulomatous periorificial dermatitis. Arch Dermatol 2002: 138: 1354-1358.
15. Misago N, Nakafusa J, Narisawa Y. Childhood granulomatous periorificial dermatitis: lupus miliaris disseminatus faciei in children? JEADV 2005: 19: 470-473.
16. Howard A, White CR. Noninfectious granulomas. In: Bolognia JL, Jorizzo JL, Rapini RP, et al. Dermatology, 1st ed. New York: Mosby, 2003: 1455-1479.
17. Morras PG, Santos SP, Imedio IL, et al. Rosacea-like demodicidosis in an immunocompromised child. Pediatr Dermatol 2003: 20: 28-30.
18. Herron MD, O'Reilly MA, Vanderhooft SL. Refractory Demodex folliculitis in five children with acute lymphoblastic leukemia. Pediatr Dermatol 2005: 22: 407-411.
19. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol 2004: 51: 499-512.
20. Draelos ZD. Silicones in topical dermatologic preparations. Cosmet Consult 2000: 1: 35-36.
21. Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol 2001: 45: 723-730.
22. Lebwohl M, Medansky RS, Russo CL, Plott RT. The comparative efficacy of sodium sulfacetamide 10% sulfur 5% lotion (Sulfacet-R) and metronidazole 0.75% (MetroGel) in the treatment of rosacea. J Geriatr Dermatol 1995: 3: 183-185.
23. Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies. Cutis 2002: 70: 271-275.
24. Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 1991: 41: 780-798.
25. Akamatsu H, Komura J, Asada Y, Miyachi Y, Niwa Y. Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenentically unrelated diseases. Arch Dermatol Res 1991: 283: 162-166.
26. Carmichael AJ, Marks R, Graupe KA, Zaumseil RP. Topical azelaic acid in the treatment of rosacea. J Dermatol Treat 1993: 4: S19-S22.
27. Maddin S. A comparison of topical azelaic acid 2% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea. J Am Acad Dermatol 1999: 40: 961-965.
28. Mills OH Jr, Kligman AM. Letter: topically applied erythromycin in rosacea. Arch Dermatol 1976: 112: 553-554.
29. Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. Int J Dermatol 1993: 32: 65-67.
30. Lachgar S, Charveron M, Gall Y, Bonafe JL. Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human keratinocytes. Dermatology 1999: 199: 25-27.
31. Gilchrest BA. Treatment of photodamage with topical tretinoin: an overview. J Am Acad Dermatol 1997: 36: S27-S36.
32. Kligman AM. Topical tretinoin for rosacea. J Dermatol Treat 1993: 4: 71-73.
33. Kligman AM. Effects of topical tretinoin on non-sunexposed protected skin of the elderly. J Am Acad Dermatol 1993: 29: 25-33.
34. Wilkin JK, Rosacea. Pathophysiology and treatment. Arch Dermatol 1994: 130: 359-362.
35. Griffiths CE, Kang S, Cllis CN, et al. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams. Arch Dermatol 1995: 131: 1037-1044.
36. Maibach H. Second-generation tetracyclines, a dermatologic overview: clinical uses and pharmacology. Cutis 1991: 48: 411-417.
37. Torresani C, Pavesi A, Manara GC. Clarithromycin versus doxycycline in the treatment of rosacea. Int J Dermatol 1997: 36: 942-946.
38. Bakar O, Demircay Z, Gurbuz O. Therapeutic potential of azithromycin in rosacea. Int J Dermatol 2004: 43: 151.
39. Torresani C. Clarithromycin: a new perspective in rosacea treatment. Int J Dermatol 1998: 37: 347-349.
40. Jansen T, Plewig G, Kligman AM. Diagnosis and treatment of rosacea fulminans. Dermatology 1994: 188: 251-254.